-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
HCV-IN-41
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2468169-71-1.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 2468169-71-1 |
| Description | HCV-IN-41 (compound 4) is a highly potent hepatitis C virus (HCV) inhibitor with an EC50 value of 0.006762 nM, 5.183 nM, 1.365 nM and 142.2 nM for HCV genotype 1b, 2a, 3a and 4a, respectively. HCV-IN-41 reduces HCV RNA replication |
Product Information
| Synonyms | HCV-IN-41|HY-147885|CS-0529837 |
| Molecular Weight | 844.99 |
| Molecular Formula | C48H56N6O8 |
| Canonical SMILES | CC(C)COC(=O)NC(C1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC3=CC=C(C=C3)C4=CC=C(C=C4)NC(=O)C5CCCN5C(=O)C(C6=CC=CC=C6)NC(=O)OCC(C)C |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 1390 |
| Exact Mass | 844.41596277 |
| Target | IC50: 0.006762 nM (HCV 1b), 5.183 nM (HCV 2a), 1.365 nM (HCV 3a), 142.2 nM (HCV 4a) |
| XLogP3-AA | 7.6 |
